 |
Dementia - Blood
Research News and Information
Definition of 'Dementia'An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness. |
Monday, March 22, 2010
29 Sep 2009 
Interest in the role of polyunsaturated fatty acids (PUFAs), particularly long-chain (LC) omega-3 (n-3) PUFAs, in mental health is increasing. This review investigates whether n-3 PUFA levels are abnormal in people with three prevalent mental health ... Read more...
Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study.
13 Sep 2009 OBJECTIVE: Several lines of evidence indicate that a decrease in the CSF concentration of amyloid beta(42) (Abeta(42)) is a potential biomarker for incident Alzheimer disease. In contrast, studies on plasma Abeta(1-40) and Abeta(1-42) peptide levels ... Read more...
Association of C-reactive protein with mild cognitive impairment.
30 Aug 2009 BACKGROUND: Inflammation is proposed to play a role in the development of Alzheimer's disease, and may also be involved in the pathogenesis of mild cognitive impairment (MCI). This study examined the association of inflammatory markers in serum or ... Read more...
Latest indexed articles for 'Dementia - Blood'
These are the very latest articles for this heading:
- Polyunsaturated fatty acid status in attention deficit hyperactivity disorder, depression, and Alzheimer's disease: towards an omega-3 index for mental health? 29 Sep 2009
- Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study. 13 Sep 2009
- Association of C-reactive protein with mild cognitive impairment. 30 Aug 2009
- Elevated C-reactive protein levels are associated with prevalent dementia in the oldest-old. 29 Jun 2009
- Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia. 13 May 2009
- Validity of estimated dietary eicosapentaenoic acid and docosahexaenoic acid intakes determined by interviewer-administered food frequency questionnaire among older adults with mild-to-moderate cognitive impairment or dementia. 9 May 2009
- [Biomarkers in cerebrospinal fluid and blood in memory complaints]
29 Apr 2009 - Serum biomarker for progranulin-associated frontotemporal lobar degeneration. 29 Apr 2009
- Neopterin and the risk of dementia in persons with Down syndrome. 12 Apr 2009
- Uric acid and dementia in community-dwelling older persons. 30 Mar 2009
- Plasma homocysteine and cerebrospinal fluid neurodegeneration biomarkers in mild cognitive impairment and dementia. 30 Mar 2009
- Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study. 29 Mar 2009
- Antibodies against oxidized LDL and apolipoprotein E polymorphism in demented patients. 18 Mar 2009
- Central obesity and increased risk of dementia more than three decades later. 15 Mar 2009
- Paraoxonase activity and dementia. 3 Mar 2009
- Incidence of abnormal metabolic parameters and weight gain induced by atypical antipsychotics in elderly patients with dementia. 27 Feb 2009
- Alterations in trace elements and oxidative stress in uremic patients with dementia. 24 Feb 2009
- High levels of serum C-reactive protein are associated with greater risk of all-cause mortality, but not dementia, in the oldest-old: results from The 90+ Study. 22 Feb 2009
- Anti-RAGE and Abeta immunoglobulin levels are related to dementia level and cognitive performance. 3 Feb 2009
- Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members.
19 Jan 2009
See a longer list of these articles.
Technical information about 'Dementia'
Definition: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
Descriptor UI: D003704
Alternative terms: Dementia; Dementias; Amentia; Amentias; Senile Paranoid Dementia; Dementias, Senile Paranoid; Paranoid Dementia, Senile; Paranoid Dementias, Senile; Senile Paranoid Dementias; Semantic Dementia; Dementia, Semantic; Dementias, Semantic; Semantic Dementias; Familial Dementia; Dementia, Familial; Dementias, Familial; Familial Dementias; Frontotemporal Lobar Degeneration; Degeneration, Frontotemporal Lobar; Degenerations, Frontotemporal Lobar; Frontotemporal Lobar Degenerations; Lobar Degeneration, Frontotemporal; Lobar Degenerations, Frontotemporal;
Related Mesh Headings: Tauopathies;
Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; diagnosis; diet therapy; drug therapy; economics; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; rehabilitation; surgery; therapy; urine; ultrasonography; virology;
Tree Number: C10.228.140.380; F03.087.400;
History Note: 1981(1963)